Is ELV or TMO cheaper?

On trailing earnings, ELV is cheaper: ELV trades at a 17.70 P/E and TMO at 28.97.

Which has grown faster, ELV or TMO?

Over the past five years, ELV grew revenue faster — ELV at a 9.97% CAGR versus TMO at 6.68%.

Does ELV or TMO pay a bigger dividend?

ELV yields 1.65% and TMO yields 0.36% based on trailing dividends and the latest price.

Is ELV or TMO more profitable?

TMO runs the higher net margin — ELV at 2.62% versus TMO at 15.18%.

Which has been the better investment, ELV or TMO?

Over the past 10-year, ELV delivered the higher annualized total return — ELV at 13.72% versus TMO at 13.46%. Past performance doesn't predict future results.

Elevance Health Inc. (ELV) vs Thermo Fisher Scientific Inc. (TMO)

ELV leads on 11 of 17 compared metrics.

A side-by-side comparison of Elevance Health Inc. and Thermo Fisher Scientific Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Thermo Fisher Scientific Inc.

$196.41B

$528.51Healthcare

Total return — ELV vs TMO

growth of $100 · last 25y

ELV +1935.4%TMO +2715.4%TMO compounded faster

ELV TMO

ELV vs TMO: by the numbers

•TMO is the larger company ($196.41B vs $92.33B market cap).
•ELV trades at the lower earnings multiple (17.70 vs 28.97 P/E).
•TMO converts more revenue to profit (15.18% vs 2.62% net margin).
•ELV grew revenue faster over the past five years (9.97% vs 6.68% CAGR).
•ELV pays the higher dividend yield (1.65% vs 0.36%).

Which is better, ELV or TMO?

Metric tally: ELV 11 · TMO 6

It depends on what you're optimizing for:

ValueELV(lower P/E)

GrowthELV(faster 5Y revenue CAGR)

IncomeELV(higher dividend yield)

QualityTMO(higher ROIC)

Metrics side by side

Valuation

Metric	ELV	TMO
P/E ratio	17.70●	28.97
Forward P/E	15.47●	21.20
P/S ratio	0.46●	4.35
P/B ratio	2.09●	3.78
PEG ratio	2.65●	4.54
EV / EBITDA	12.78●	22.46
FCF yield	7.03%●	3.43%

Profitability

Metric	ELV	TMO
Gross margin	23.16%	39.41%●
Operating margin	3.81%	17.76%●
Net margin	2.62%	15.18%●
ROE	11.94%	13.21%●
ROIC	6.65%	7.58%●

Dividends

Metric	ELV	TMO
Dividend yield	1.65%●	0.36%
Payout ratio	27.32%	10.58%

Growth (annualized)

Metric	ELV	TMO
Revenue CAGR (5Y)	9.97%●	6.68%
EPS CAGR (5Y)	6.67%●	1.99%
FCF CAGR (5Y)	-7.76%	-0.19%●
Total return CAGR (5Y)	2.85%●	0.95%

Frequently asked

Which is better, ELV or TMO?: It depends on your goal. value: ELV (lower P/E); growth: ELV (faster 5Y revenue CAGR); income: ELV (higher dividend yield); quality: TMO (higher ROIC). Across all compared metrics, ELV leads 11 to 6.
Is ELV or TMO cheaper?: On trailing earnings, ELV is cheaper: ELV trades at a 17.70 P/E and TMO at 28.97.
Which has grown faster, ELV or TMO?: Over the past five years, ELV grew revenue faster — ELV at a 9.97% CAGR versus TMO at 6.68%.
Does ELV or TMO pay a bigger dividend?: ELV yields 1.65% and TMO yields 0.36% based on trailing dividends and the latest price.
Is ELV or TMO more profitable?: TMO runs the higher net margin — ELV at 2.62% versus TMO at 15.18%.
Which has been the better investment, ELV or TMO?: Over the past 10-year, ELV delivered the higher annualized total return — ELV at 13.72% versus TMO at 13.46%. Past performance doesn't predict future results.

Go deeper

Full ELV analysis Full TMO analysis Interactive comparison tool

Dig into the metrics

Elevance Health P/E ratio Thermo Fisher Scientific P/E ratio Elevance Health dividend yield Thermo Fisher Scientific dividend yield Elevance Health ROE Thermo Fisher Scientific ROE Elevance Health operating margin Thermo Fisher Scientific operating margin Elevance Health revenue growth Thermo Fisher Scientific revenue growth Elevance Health free cash flow Thermo Fisher Scientific free cash flow

Elevance Health & Thermo Fisher Scientific appear in these rankings

Highest FCF Yield Stocks Best 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 13, 2026.